GRAMANTIERI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 841
EU - Europa 266
AS - Asia 39
AF - Africa 9
SA - Sud America 4
OC - Oceania 2
Totale 1.161
Nazione #
US - Stati Uniti d'America 828
FR - Francia 60
IT - Italia 60
DE - Germania 35
IE - Irlanda 35
BG - Bulgaria 28
GB - Regno Unito 19
CA - Canada 13
AE - Emirati Arabi Uniti 10
CZ - Repubblica Ceca 9
IN - India 8
ZA - Sudafrica 7
CN - Cina 5
FI - Finlandia 5
JP - Giappone 4
RU - Federazione Russa 4
CL - Cile 3
NL - Olanda 3
TH - Thailandia 3
VN - Vietnam 3
GR - Grecia 2
IQ - Iraq 2
RO - Romania 2
AU - Australia 1
BD - Bangladesh 1
BE - Belgio 1
BR - Brasile 1
EG - Egitto 1
ES - Italia 1
GH - Ghana 1
IR - Iran 1
KR - Corea 1
NZ - Nuova Zelanda 1
PL - Polonia 1
TR - Turchia 1
UA - Ucraina 1
Totale 1.161
Città #
Ashburn 154
Columbus 98
Santa Cruz 68
Fairfield 50
Dublin 35
Seattle 35
Houston 29
Sofia 28
Buffalo 26
Bologna 25
Woodbridge 24
Cambridge 20
Chicago 19
Boardman 16
Southend 14
Wilmington 12
Clearwater 9
Mountain View 8
Las Vegas 7
Medolla 7
Paris 7
Atlanta 6
Berlin 6
Muizenberg 6
Pune 6
Bremen 5
Castelletto sopra Ticino 5
Los Angeles 5
Council Bluffs 4
Dallas 4
Helsinki 4
New York 4
Ottawa 4
San Diego 4
Tappahannock 4
Ann Arbor 3
Beauharnois 3
Cesena 3
Chandler 3
Crugers 3
Dong Ket 3
Fleming Island 3
Milpitas 3
Riva 3
Basking Ridge 2
Chiang Mai 2
Domnesti 2
Falls Church 2
Florence 2
Groningen 2
Grossmuehlingen 2
Harbin 2
Henderson 2
Jacksonville 2
Kyoto 2
Lake Forest 2
Nasiriyah 2
Phoenix 2
Santa Maria Capua Vetere 2
Scranton 2
Aachen 1
Accra 1
Auckland 1
Austin 1
Bangkok 1
Beijing 1
Cairo 1
Costabissara 1
Daegu 1
Dulles 1
Edison 1
Forlì 1
Frankfurt Am Main 1
Frankfurt am Main 1
Galveston 1
Halle 1
Jaboatao dos Guararapes 1
Kiato 1
Landshut 1
Lombard 1
London 1
Montreal 1
Munich 1
Murcia 1
Nagasaki 1
Nice 1
Norwalk 1
Nottingham 1
Nuremberg 1
Oakland 1
Omaha 1
Padova 1
Palo Alto 1
Pasadena 1
Philadelphia 1
Pieve di Cento 1
Piove Di Sacco 1
Providence 1
Provo 1
Ravenna 1
Totale 857
Nome #
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area, file 1a10cfb3-dda9-49f9-874e-b79e9e0d26ef 142
Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma, file e1dcb32f-98c5-7715-e053-1705fe0a6cc9 104
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC, file e1dcb32d-8fd4-7715-e053-1705fe0a6cc9 98
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer, file e1dcb332-11ba-7715-e053-1705fe0a6cc9 85
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma, file e1dcb337-9a4e-7715-e053-1705fe0a6cc9 77
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin, file e1dcb333-599c-7715-e053-1705fe0a6cc9 72
Direct antiviral treatments for hepatitis c virus have off-target effects of oncologic relevance in hepatocellular carcinoma, file e1dcb337-11aa-7715-e053-1705fe0a6cc9 71
Corrigendum: Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma (Scientific Reports (2017) 7 (44685) DOI: 10.1038/srep44685), file e1dcb330-d865-7715-e053-1705fe0a6cc9 70
TP53/MicroRNA interplay in hepatocellular carcinoma, file e1dcb32f-8553-7715-e053-1705fe0a6cc9 67
MicroRNAs in Animal Models of HCC, file e1dcb333-d6a5-7715-e053-1705fe0a6cc9 65
LncRNAs as novel players in hepatocellular carcinoma recurrence, file e1dcb332-2e4e-7715-e053-1705fe0a6cc9 63
Hepatic cancer stem cells: Molecular mechanisms, therapeutic implications, and circulating biomarkers, file e1dcb338-e92f-7715-e053-1705fe0a6cc9 35
Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas, file e1dcb331-a1f5-7715-e053-1705fe0a6cc9 34
MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma, file 2c7fa449-55fd-4caf-9253-238cda1b1804 18
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma, file 5b6ebf86-7752-408a-8718-2e00b816c01b 18
Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions, file e1dcb338-d0d6-7715-e053-1705fe0a6cc9 18
Notch signaling regulation in HCC: From hepatitis virus to non‐coding rnas, file e1dcb338-a069-7715-e053-1705fe0a6cc9 16
Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research, file 823d5da4-1b5c-41c4-9b22-a2b8256f596f 15
MiR-122 targets serpinB3 and is involved in sorafenib resistance in hepatocellular carcinoma, file 634dd42e-a390-486d-ba6b-1b9a172305be 14
MiR-122 targets serpinB3 and is involved in sorafenib resistance in hepatocellular carcinoma, file 9890f55c-a514-4a64-b997-2776e5a74e46 13
Brivanib in combination with Notch3 silencing shows potent activity in tumour models, file d0538d94-e4db-4607-823c-d7c83688dd55 13
Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas, file e1dcb338-2b93-7715-e053-1705fe0a6cc9 11
MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma, file e1dcb338-9901-7715-e053-1705fe0a6cc9 10
Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas, file e1dcb338-6ff2-7715-e053-1705fe0a6cc9 9
Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma, file e1dcb32f-968a-7715-e053-1705fe0a6cc9 7
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study, file b5711546-690b-4b71-9bad-de6bbaaa7306 6
T.N.28 P53 IS REGULATED BY NOTCH3 SIGNALLING VIA MDM2 IN HEPATOCELLULAR CARCINOMA, file e1dcb32f-ee4b-7715-e053-1705fe0a6cc9 6
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma, file c892ec1c-1efb-4f78-9067-5f11b2795f00 4
Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3b phosphorylation and p21 down-regulation in hepatocellular carcinoma., file e1dcb32c-548d-7715-e053-1705fe0a6cc9 4
MicroRNA as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much s missing?, file 68024b76-dd0a-4464-812a-c800da20a589 3
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area, file 88259765-b738-4911-9232-cb27632f9f64 3
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma, file e1dcb32e-8c79-7715-e053-1705fe0a6cc9 3
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma, file e874a371-52db-44c9-897c-678fd5a2a054 3
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma, file 88744aef-e776-43e9-bd26-b3959cd4d446 2
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma, file e039c172-1078-4ffd-ad1a-1ee66902a2bb 2
Targeting notch3 in hepatocellular carcinoma: Molecular mechanisms and therapeutic perspectives, file e1dcb32f-4a8a-7715-e053-1705fe0a6cc9 2
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches, file e1dcb330-bdfb-7715-e053-1705fe0a6cc9 2
Emerging role of microRNAs in the treatment of hepatocellular carcinoma, file e1dcb339-7cf6-7715-e053-1705fe0a6cc9 2
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response, file 4d7e3739-c992-4b9b-b4a6-26877a3e649b 1
Brivanib in combination with Notch3 silencing shows potent activity in tumour models, file 59f78bf8-d6bf-4c43-ba22-cf5814bd329f 1
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis, file e1dcb330-306f-7715-e053-1705fe0a6cc9 1
Animal models of hepatocellular carcinoma prevention, file e1dcb339-6e80-7715-e053-1705fe0a6cc9 1
Totale 1.191
Categoria #
all - tutte 4.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.339


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/202079 0 0 0 6 7 7 6 12 13 12 11 5
2020/2021154 10 12 7 6 10 10 17 11 14 29 14 14
2021/2022253 13 20 13 10 22 4 14 15 9 19 90 24
2022/2023311 8 12 72 50 22 14 12 14 48 17 41 1
2023/2024390 2 7 6 13 21 70 108 28 24 6 105 0
Totale 1.191